SJM
38
-3
XRAY
31
-3
SWN
77
4
FRT
36
-2
EMC
53
-3
MMM
52
2
LEN
55
-9
GM
58
-2
PSX
40
-4
MCD
67
2
MAT
51
-3
OMC
64
-2
VLO
40
-5
SYF
65
-6
BRK.B
42
-3
FIS
46
-4
XRX
52
-3
TXT
58
-2
MTCH
44
-4
ISRG
68
-3
SJM
38
-3
XRAY
31
-3
SWN
77
4
FRT
36
-2
EMC
53
-3
MMM
52
2
LEN
55
-9
GM
58
-2
PSX
40
-4
MCD
67
2
MAT
51
-3
OMC
64
-2
VLO
40
-5
SYF
65
-6
BRK.B
42
-3
FIS
46
-4
XRX
52
-3
TXT
58
-2
MTCH
44
-4
ISRG
68
-3
Financhill
Back

Cara Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
11

CARA
Cara Therapeutics

Last Price:
0.30
Seasonality Move:
-11.19%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
11
Cara Therapeutics (CARA) is a Sell

Is Cara Therapeutics a Buy, Sell or Hold?

  • The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CARA Stock Price Chart

What is Cara Therapeutics's stock price today?

  • The Cara Therapeutics share price today is $0.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CARA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.76 Sell
Chaikin Money Flow: -366348 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.29 - 0.35) Sell
Bollinger Bands (100): (0.26 - 0.64) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CARA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.28 Buy
20-day SMA: 0.31 Sell
50-day SMA: 0.33 Sell
200-day SMA: 0.61 Sell
8-day EMA: 0.29 Buy
20-day EMA: 0.31 Sell
50-day EMA: 0.35 Sell
200-day EMA: 0.92 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Cara Therapeutics Earnings Growth & CARA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Cara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):